Curr Atheroscler Rep 24(11):867884
Its like a two-in-one package, tackling both weight and high blood pressure issues, while also addressing blood sugar concerns
"GLP-1s represent an important advancement in obesity care but these medications can present challenges, including gastrointestinal side effects Nutrition therapy and lifestyle support are essential components to address these challenges", says Dariush Mozaffarian, MD, DrPH, from Tufts University
[DOI] [PubMed] [Google Scholar] 37.Mota-Zamorano S., Gonzlez L.M., Robles N.R., Valdivielso J.M., Cancho B., Lpez-Gmez J., Gervasini G
While both medications are powerful tools for weight management, they work best when combined with long-term lifestyle changes
Rare monogenic causes of obesity Setmelanotide is a daily, subcutaneously administered melanocortin 4 receptor agonist, which has demonstrated benefit in reducing weight and hunger scores in people with rare monogenic causes of obesity (Table 1, recommendation 12)